Internal Medicine, Hematology & Oncology · Tuscaloosa, AL
NPI
1518946508
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1410 McFarland Blvd N
Tuscaloosa, AL, 35406
Phone (205) 345-8208
Groups this clinician bills Medicare through
Medicare paid, 2024
$106K
6,193 services
Medicare patients, 2024
251
Average age 74
Drug cost, 2024
$2.6M
799 prescriptions
Company payments, 2025
$6,908
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn A Arrambide was code 99214 (office e&m - established), 285 times for 144 patients. In total Kathryn A Arrambide billed 6,193 services in 72 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-05-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 285 | 144 | $79.06 | $23K |
| 36415 Venipuncture Blood Collection | Office | 169 | 72 | $8.65 | $1,462 |
| 85025 Blood Count | Office | 164 | 77 | $7.61 | $1,248 |
| 99213 Office E&M - Established | Office | 114 | 82 | $56.19 | $6,406 |
| 99214 Office E&M - Established | Facility | 64 | 24 | $70.45 | $4,509 |
| 99204 Office E&M - New | Office | 30 | 30 | $110.47 | $3,314 |
| 99205 Office E&M - New | Office | 23 | 23 | $140.60 | $3,234 |
| 99213 Office E&M - Established | Facility | 20 | 15 | $49.44 | $989 |
| 99215 Office E&M - Established | Office | 18 | 16 | $113.85 | $2,049 |
| 96375 Injection Administration | Office | 17 | 13 | $8.75 | $149 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 17 | 12 | $0.59 | $10.08 |
| 96413 Chemotherapy Administration | Office | 15 | 12 | $84.86 | $1,273 |
| 99204 Office E&M - New | Facility | 15 | 15 | $93.03 | $1,395 |
| 99205 Office E&M - New | Facility | 14 | 14 | $119.23 | $1,669 |
By year: 2022 $79K for 9,086 services; 2023 $418K for 51,825 services; 2024 $106K for 6,193 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 169 | 72 | $8.65 | $1,462 |
| 85025 Blood Count | 164 | 77 | $7.61 | $1,248 |
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn A Arrambide prescribed most often to Medicare patients was Letrozole, with 70 prescriptions and refills. In total Kathryn A Arrambide wrote 799 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 70 | 117 | 21 | $924 |
| Anastrozole Generic | 55 | 125 | 19 | $726 |
| Hydroxyurea Generic | 32 | 59 | Under 11 | $436 |
| Prednisone Generic | 24 | 24 | 11 | $95.08 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | 13 | $833 |
| Brukinsa Zanubrutinib | 21 | 21 | Under 11 | $212K |
| Gabapentin Generic | 20 | 26 | Under 11 | $131 |
| Imatinib Mesylate Generic | 19 | 19 | Under 11 | $11K |
| Ondansetron Odt Ondansetron | 18 | 18 | Under 11 | $339 |
| Imbruvica Ibrutinib | 18 | 18 | Under 11 | $284K |
| Xtandi Enzalutamide | 18 | 18 | Under 11 | $236K |
| Eliquis Apixaban | 18 | 18 | Under 11 | $10K |
| Palonosetron Hcl Generic | 16 | 16 | Under 11 | $2,165 |
| Fluconazole Generic | 14 | 14 | Under 11 | $118 |
| Prolia Denosumab | 14 | 84 | Under 11 | $24K |
Brand drugs: 275 claims; generic drugs: 524 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn A Arrambide $6,908 ($6,908 in general payments such as food, travel and fees) from 30 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $4,484.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 9 | $4,484 |
| Daiichi Sankyo Inc. 4568.T | 1 | $650 |
| Cardinal Health 110 LLC | 1 | $275 |
| Janssen Biotech, Inc. JNJ | 6 | $188 |
| Pfizer Inc. PFE | 13 | $155 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $137 |
| Array Biopharma Inc PFE | 4 | $88.52 |
| Genzyme Corporation SNY | 3 | $87.25 |
| Incyte Corporation INCY | 4 | $80.57 |
| Pharmacosmos Therapeutics Inc. | 4 | $80.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.